// App-Quantinova.ai

224 : HNF4α Gene Signature Can Accurately Predict Stage Specific Disease Progression In Cirrhosis And Hepatocellular Carcinoma

Researchers

Presenter

  • Sumedha S. Gunewardena

Principal Investigators

  • Ian Huck

  • Chad Walesky

  • Steven A. Weinman

  • Anusha Vittal

  • Josiah Cox

  • Maura O'Neil

  • Udayan Apte

Medical Centers

  • Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Cancer Center, Kansas City, KS

  • Department of Molecular & Integrative Physiology, University of Kansas Medical Center, Kansas City, KS

  • Pediatrics, University of Kansas Medical Center, Kansas City, KS

  • Internal Medicine, University of Kansas Medical Center, Kansas City, KS

  • Pediatrics, University of Kansas Medical Center, Kansas City, KS

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Advanced biliary tract carcinoma

  • Venous thrombosis

  • Cirrhosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved